China CAS:439239-92-6 Manufacturer

We insist over the principle of enhancement of 'High high quality, Efficiency, Sincerity and Down-to-earth working approach' to offer you with superb assistance of processing for CAS:439239-92-6, Top quality, timely company and Aggressive cost, all win us a superior fame in xxx field despite the international intense competition.
CAS:439239-92-6, Our company has a skillful sales team, strong economic foundation, great technical force, advanced equipment, complete testing means, and excellent after-sales services. Our goods have beautiful appearance, fine workmanship and superior quality and win the unanimous approvals of the customers all over the world.

Hot Products

  • Levonorgestrel

    Levonorgestrel

    Levonorgestrel has speficications of CP/EP/USP. DMF,GMP and CEP available.

    CAS:797-63-7

  • Estriol

    Estriol

    Estriol has CP, EP, USP specifications. DMF under filing.

    CAS:50-27-1

  • Eplerenone

    Eplerenone

    Eplerenone has EP specifications. CEP available and FDA approved.

    CAS:107724-20-9

  • Valganciclovir Hydrochloride

    Valganciclovir Hydrochloride

    Valganciclovir Hydrochloride has USP specification. DMF approved.

    CAS:175865-59-5

  • 16alpha-Hydroxyprednisolone Acetate

    16alpha-Hydroxyprednisolone Acetate

    16alpha-Hydroxyprednisolone Acetate is used to observe interaction of some steroid drugs with β-cyclodextrin polymer to calculate the relative strengh of interaction between the hydrophobicity parameters of the drugs and the strenght of the drug-β-​cyclodextrin polymer.

    CAS:86401-80-1

  • Abiraterone

    Abiraterone

    Abiraterone is a steroidal cytochrome P 450 17α-hydroxylase-17,20-lyase inhibitor (CYP17), It is used in combination with prednisone to treat patients with metastatic castration-resistant prostate cancer (prostate cancer that is resistant to medical or surgical treatments that lower testosterone and has already spread to other parts of the body) and metastatic high-risk castration-sensitive prostate cancer.

    CAS:154229-19-3

Send Inquiry

X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept